Menu Close

Carterra joins CoVIC and the Bill & Melinda Gates Foundation in the fight against COVID-19

Using its LSA platform, Carterra can perform high-throughput assays to provide full antibody characterization data for antibodies in the CoVIC panel. Quantifying a variety of antibody features such as affinity for virus protein targets is important for a detailed understanding of mechanisms of action and how different antibodies could have complementary activities. Click here to read the press release.


Related News